Publications
-
1.
2013Hongyuan Cao; Lisa M. Lavange; Joseph F. Heyse; T. Christopher Mast; Michael R. Kosorok
Medical records-based postmarketing safety evaluation of rare events with uncertain status
Journal of Biopharmaceutical Statistics. 2013;23(1):201-212. -
2.
2012William R. Carpenter; Anne-Marie Meyer; Amy P. Abernethy; Til Stürmer; Michael R. Kosorok
A framework for understanding cancer comparative effectiveness research data needs
Journal of Clinical Epidemiology. 2012;65(11):1150-1158. -
3.
2012Anne-Marie Meyer; William R. Carpenter; Amy P. Abernethy; Til Stürmer; Michael R. Kosorok
Data for cancer comparative effectiveness research: Past, present, and future potential
Cancer. 2012;118(21):5186-5197.
Similar Experts
- Publications
- 143
- 104
- 152
- 141
- 102
Journals
-
Publications
-
11
-
10
-
10
-
8
-
7
Grants
-
1.
Richard Boucher; William Bennett; Brian Button; C. Davis; Claire Doerschuk; Scott Donaldson; Camille Ehre; Barbara Grubb; Ashley Henderson; David Hill; Mehmet Kesimer; Michael Kosorok; Alessandra Livraghi-Butrico; Wanda O'Neal; Bahjat Qaqish; Michael Rubinstein; John Sheehan; Nadia Bendahmane; Fred Fuller; Claudia Salazar
Novel Therapies for Muco-Obstructive Lung Diseases
6/15/2012 - 5/31/2017
Sponsor: NIH National Heart, Lung, and Blood Institute (NHLBI)
Funding: $ 2,545,908.00
-
2.
Charles Cairns; Amy Ising; Michael Kosorok; Richard Marciano; David Potenziani
The North Carolina Bio-Preparedness Collaborative (NCB-Prepared)
6/1/2010 - 4/12/2013
Sponsor: Department of Homeland Security (DHS)
Funding: $ 5,000,000.00
-
3.
Charles Cairns; Amy Ising; Michael Kosorok; Richard Marciano; David Potenziani; David Richardson
The North Carolina Bio-Preparedness Collaborative (NCB-Prepared)
6/1/2010 - 4/12/2013
Sponsor: Department of Homeland Security (DHS)
Funding: $ 2,854,379.00
Institutional Network
-
Internal OrganizationsShared Pub.
-
3
-
2
-
2
-
1
-
1
-
1
-
External OrganizationsShared Pub.
-
40
-
19
-
15
-
8
-
7
-
6

